S&P 500 Futures
(-0.08%) 5 303.75 points
Dow J Futures
(-0.09%) 40 107 points
Nasdaq Futures
(-0.07%) 18 491 points
Oil
(0.54%) $81.79
Gas
(-0.70%) $1.706
Gold
(0.05%) $2 213.70
Silver
(-0.81%) $24.55
Platinum
(-0.28%) $907.15
USD/EUR
(0.32%) $0.926
USD/NOK
(0.63%) $10.84
USD/GBP
(0.24%) $0.793
USD/RUB
(-0.15%) $92.30

Realtime updates for Scopus Biopharma Inc. [SCPS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated27 Mar 2024 @ 15:37

0.00% $ 0.00240

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 15:37):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers...

Stats
Today's Volume 39 294.00
Average Volume 3 204.00
Market Cap 101 002
EPS $-0.0658 ( 2023-08-11 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0100
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2021-11-23 Greenspan Ira Scott Sell 3 000 000 W Warrants
2021-11-23 Lamstein Joshua R Sell 3 000 000 W Warrants
2021-06-01 Hopper Paul Buy 6 333 Common Stock
2020-12-15 Hopper Paul Buy 0 Common Stock
2020-12-15 Hopper Paul Sell 0 Common Stock
INSIDER POWER
0.00
Last 55 transactions
Buy: 2 180 518 | Sell: 6 965 870

Scopus Biopharma Inc. Correlation

10 Most Positive Correlations
KTTA0.932
ISPO0.915
UTME0.91
SMIT0.91
MTP0.909
CREG0.908
NCBS0.906
HOL0.905
NKTX0.904
SWVL0.902
10 Most Negative Correlations
GDNR-0.933
AMYT-0.924
NWLI-0.913
BRAC-0.911
EMLD-0.91
BTWN-0.91
CDZI-0.909
AVAC-0.909
PROF-0.908
EXAS-0.908

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Scopus Biopharma Inc. Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.550
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.0658
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.0807
Q4 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.0821

Financial Reports:

No articles found.

Scopus Biopharma Inc.

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators